How One Biotech Venture Is Breaking The Cost Barrier In Manufacturing MAbs For Infectious Diseases
Executive Summary
Biotech official explains how creating partnerships with NGOs, using innovative cell cloning technology and cutting costs is allowing startup to develop new monoclonal antibody treatments for infectious diseases in developing countries, including a new MAb for Ebola.